As shown in Table 1, the included studies employed AF-albumin adduct level [12, 21, 22], 249ser TP53 mutation [19–21] and groundnut consumption [19, 20] as methods of AF exposure assessment in liver cirrhosis patients. The gene discussed is TP53; the disease is atrial fibrillation.